{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:23:12Z","timestamp":1792153392789,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/tp.0000000000000525","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T13:14:07Z","timestamp":1421846047000},"page":"1423-1430","source":"Crossref","is-referenced-by-count":70,"title":["Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization"],"prefix":"10.1097","volume":"99","author":[{"given":"Ashley A.","family":"Vo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jua","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mirocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villicana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198502283120905","article-title":"The quality of life of patients with end-stage renal disease.","volume":"312","author":"Evans","year":"1985","journal-title":"N Engl J Med"},{"key":"R2-23-20210129","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"key":"R4-23-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation.","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-23-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"R6-23-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-6143.2005.01214.x","article-title":"Intravenous gammaglobulin (IVIg): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant"},{"key":"R7-23-20210129","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH Ig02 trial.","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R8-23-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"R9-23-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"R10-23-20210129","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"R11-23-20210129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"R12-23-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/TP.0b013e31821eab8a","article-title":"Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy.","volume":"92","author":"Lai","year":"2011","journal-title":"Transplantation"},{"key":"R13-23-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study.","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R14-23-20210129","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1600-6143.2008.02262.x","article-title":"The spectrum of antibody-mediated renal allograft injury: implications for treatment.","volume":"8","author":"Gloor","year":"2008","journal-title":"Am J Transplant"},{"key":"R15-23-20210129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R16-23-20210129","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome.","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-23-20210129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival.","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R18-23-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches.","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"R19-23-20210129","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R20-23-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R21-23-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R22-23-20210129","first-page":"85","article-title":"Complement-binding anti-HLA antibodies and kidney transplantation.","volume":"370","author":"Lefaucheur","year":"2014","journal-title":"N Engl J Med"},{"key":"R23-23-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/TP.0b013e31827be3c1","article-title":"Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA.","volume":"95","author":"Zachary","year":"2013","journal-title":"Transplantation"},{"key":"R24-23-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","article-title":"Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period.","volume":"12","author":"Kohei","year":"2012","journal-title":"Am J Transplant"},{"key":"R25-23-20210129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/ajt.12308","article-title":"Cryptic B cell response to renal transplantation.","volume":"13","author":"Lynch","year":"2013","journal-title":"Am J Transplant"},{"key":"R26-23-20210129","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIg and rituximab.","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"R27-23-20210129","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-009-1386-4","article-title":"Advances in diagnosing and managing antibody-mediated rejection.","volume":"25","author":"Jordan","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R28-23-20210129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.1426","article-title":"Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.","volume":"34","author":"Kim","year":"2014","journal-title":"Pharmacotherapy"},{"key":"R29-23-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituxmab combined with intravenous immunoglobulin for desensitization of renal transplant recipients.","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"R30-23-20210129","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch.","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"R31-23-20210129","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study.","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"R32-23-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R34-23-20210129","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"R35-23-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-6143.2007.02017.x","article-title":"Analysis of subcutaneous (Sq) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIg and rituximab.","volume":"8","author":"Vo","year":"2008","journal-title":"Am J Transplant"},{"key":"R36-23-20210129","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1600-6143.2006.01472.x","article-title":"Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIg.","volume":"6","author":"Vo","year":"2006","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T06:43:28Z","timestamp":1690872208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201507000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000525","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}